NCT00169728View on ClinicalTrials.gov

Vaccination of Children Following Allogeneic Stem Cell Transplantation

PHASE3CompletedINTERVENTIONAL
Enrollment

53

Participants

Timeline

Start Date

September 30, 2003

Primary Completion Date

June 30, 2006

Study Completion Date

October 31, 2006

Conditions
Allogeneic Haematopoietic Stem Cell Transplantation
Interventions
BIOLOGICAL

DTaP-IPV-HBV/Hib combination vaccine, Infanrix hexa

BIOLOGICAL

heptavalent pneumococcal conjugate vaccine, Prevenar

Trial Locations (11)

D-13353

University Childrens Hospital, Berlin

D-40225

University Children Hospital, Düsseldorf

D-91054

University Children Hospital, Erlangen

D-60590

University Children Hospital, Frankfurt

D-79106

University Childrens Hospital, Freiburg im Breisgau

D-35385

University Childrens Hospital, Giessen

D-20246

University Childrens Hospital, Hamburg

D-30625

University Childrens Hospital, Hanover

D-07740

University Childrens Hospital, Jena

D-48129

University Childrens Hospital, Münster

D-72076

University Childrens Hospital, Tübingen

Sponsors

Collaborators (1)

GlaxoSmithKline
All Listed Sponsors
collaborator

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

collaborator

GlaxoSmithKline

INDUSTRY

lead

Heinrich-Heine University, Duesseldorf

OTHER